Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03395132
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:49.529074+00:00
Published At
2025-02-24T00:00:00+00:00
Record Updated At
2025-02-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Infected Atopic Dermatitis/Eczema"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-24"
protocolSection.identificationModule.nctId
"NCT03395132"
protocolSection.identificationModule.officialTitle
"Efficacy and Safety of Fucicort\u00ae Lipid Cream Compared to Combination Treatment With Fucidin\u00ae Cream Followed by Betamethasone (Lianbang Beisong\u00ae) Cream and Fucicort\u00ae Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Infected Atopic Dermatitis/Eczema (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.